CME vs NDAQ
CME Group and Nasdaq, Inc., both Financial Services
CME Group is the larger company at $89B against $47B. On trailing earnings CME is the cheaper of the two at a P/E of 23.8 against 27.3, a gap that is only a bargain if the two are growing at similar rates. Over the past year CME returned +11% against +6.4% for NDAQ. The RyuScore puts CME ahead, 64 against 59 out of 100.
| Figure | CME | NDAQ |
|---|---|---|
| Last close | $281 | $93.66 |
| Market cap | $89B | $47B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | 23.8 | 27.3 |
| Dividend yield | 1.8% | 1.1% |
| 1-year return | +11% | +6.4% |
| 5-year return | +82% | +54% |
| RyuScoresector-relative, 1–10 | 64/100 | 59/100 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
CME Group
Revenue of $1.7B in Q2 2026, net income $1.0B. Its largest reported line is Clearingandtransactionfees, 79% of the disclosed total.
Nasdaq, Inc.
Revenue of $2.5B in Q2 2026, net income $507M. Its largest reported line is Market Services, 54% of the disclosed total.
Open these two in the interactive comparison to add more names, change the period or see the correlation.